Your browser doesn't support javascript.
loading
[Medical Treatments in Oncology 2023].
Comandone, Alessandro; Boglione, Antonella; Comandone, Tiziana.
Afiliação
  • Comandone A; SC Oncologia Medica - Ospedale San Giovanni Bosco, Torino; Gruppo Italiano Tumori Rari.
  • Boglione A; SC Oncologia Medica - Ospedale San Giovanni Bosco, Torino; Gruppo Italiano Tumori Rari.
  • Comandone T; Scuola di Specializzazione in Farmacologia Ospedaliera- Università degli studi di Torino; Gruppo Italiano Tumori Rari.
G Ital Nefrol ; 40(Suppl 81)2023 Oct 03.
Article em It | MEDLINE | ID: mdl-38007823
ABSTRACT
Medical Oncology since the beginning of the new millennium has recognized a great positive evolution in the care of cancer. In fact, for more than 60 years the two classical pillars of the antineoplastic therapy were hormone therapies mainly applied in breast, prostate and thyroid cancer, and chemotherapy seldom curative and heavily toxic. Nowadays some new treatments are available thanks to the advances in genomics, proteomics and molecular biology of tumor cells either to the advances in immunology studies. Specific pathways in cancer cells have been recognized and hit by targeted drugs. Monoclonal antibodies, tyrosine kinase inhibitors, checkpoint inhibitors, cellular therapies and vaccines are the new tools for oncologists. The last discovery is the antibody-drug conjugates (ADCs), which combine monoclonal antibodies with cytotoxic drugs. Unfortunately, these impressive advances have caused the appearance of new scientific, social, and financial problems. All these topics are discussed in the article.
Assuntos
Palavras-chave
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans / Male Idioma: It Revista: G Ital Nefrol Assunto da revista: NEFROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans / Male Idioma: It Revista: G Ital Nefrol Assunto da revista: NEFROLOGIA Ano de publicação: 2023 Tipo de documento: Article